{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:05:55Z","timestamp":1789628755154,"version":"build-2803163510"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,9,25]],"date-time":"2009-09-25T00:00:00Z","timestamp":1253836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Immunopathol"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1007\/s00281-009-0178-z","type":"journal-article","created":{"date-parts":[[2009,9,24]],"date-time":"2009-09-24T14:09:19Z","timestamp":1253801359000},"page":"439-453","source":"Crossref","is-referenced-by-count":125,"title":["The pathological spectrum of CNS inflammatory demyelinating diseases"],"prefix":"10.1007","volume":"31","author":[{"given":"Wei","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia F.","family":"Lucchinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,9,25]]},"reference":[{"key":"178_CR1","volume-title":"Pathological anatomy: illustrations on elementary forms of disease","author":"R Carswell","year":"1838","unstructured":"Carswell R (1838) Pathological anatomy: illustrations on elementary forms of disease. Logman, London"},{"key":"178_CR2","volume-title":"Lecons sur les maladies du systeme nerveux faites a la salpetriere","author":"J Charcot","year":"1880","unstructured":"Charcot J (1880) Lecons sur les maladies du systeme nerveux faites a la salpetriere. Cert et fils, Paris"},{"key":"178_CR3","first-page":"554","volume":"41","author":"JM Charcot","year":"1848","unstructured":"Charcot JM (1848) Histologie de la scl\u00e9rose en plaques. Gaz Hop Civ Mil 41:554\u2013566","journal-title":"Gaz Hop Civ Mil"},{"key":"178_CR4","first-page":"1829","volume-title":"Anatomie pathologique du corps humain","author":"J Cruveilier","year":"1880","unstructured":"Cruveilier J (1880) Anatomie pathologique du corps humain. JB Paris, Bailliere pp 1829\u20131842"},{"key":"178_CR5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0165-5728(87)90082-8","volume":"16","author":"U Traugott","year":"1983","unstructured":"Traugott U (1983) Multiple sclerosis: relevance of class I and class II MHC- expressing cells to lesion development. J Neuroimmunol 16:283\u2013302","journal-title":"J Neuroimmunol"},{"key":"178_CR6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ana.410310317","volume":"31","author":"DW Anderson","year":"1992","unstructured":"Anderson DW, Ellenberg JH, Leventhal CM et al (1992) Revised estimate of the prevalence of multiple sclerosis in the United States. Ann Neurol 31:333\u2013336","journal-title":"Ann Neurol"},{"key":"178_CR7","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1212\/01.WNL.0000094316.90240.EB","volume":"61","author":"WT Mayr","year":"1373","unstructured":"Mayr WT, Pittock SJ, McClelland RL et al (1373) Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985\u20132000. Neurology 61:1373\u20131377","journal-title":"Neurology"},{"key":"178_CR8","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/ana.410380514","volume":"38","author":"W Bruck","year":"1995","unstructured":"Bruck W, Porada P, Poser S et al (1995) Monocyte-macrophage differentiation in early multiple sclerosis lesions. Ann Neurol 38:788\u2013796","journal-title":"Ann Neurol"},{"key":"178_CR9","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.1255","volume":"50","author":"JW Prineas","year":"2001","unstructured":"Prineas JW, Kwon EE, Cho ES et al (2001) Immunopathology of secondary-progressive multiple sclerosis. Ann Neurol 50:646\u2013657","journal-title":"Ann Neurol"},{"key":"178_CR10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/5532","volume":"5","author":"CP Genain","year":"1999","unstructured":"Genain CP, Cannella B, Hauser SL, Raine CS (1999) Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat Med 5:170\u2013175","journal-title":"Nat Med"},{"key":"178_CR11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jnen\/62.1.25","volume":"62","author":"F Aboul-Enein","year":"2003","unstructured":"Aboul-Enein F, Rauschka H, Kornek B et al (2003) Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases. J Neuropathol Exp Neurol 62:25\u201333","journal-title":"J Neuropathol Exp Neurol"},{"key":"178_CR12","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","volume":"47","author":"CF Lucchinetti","year":"2000","unstructured":"Lucchinetti CF, Bruck W, Parisi J et al (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707\u2013717","journal-title":"Ann Neurol"},{"key":"178_CR13","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/ana.20182","volume":"56","author":"CF Lucchinetti","year":"2004","unstructured":"Lucchinetti CF, Bruck W, Lassmann H (2004) Evidence for pathogenic heterogeneity in multiple sclerosis. Ann Neurol 56:308","journal-title":"Ann Neurol"},{"key":"178_CR14","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ana.20016","volume":"55","author":"MH Barnett","year":"2004","unstructured":"Barnett MH, Prineas JW (2004) Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55:458\u2013468","journal-title":"Ann Neurol"},{"key":"178_CR15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ana.20188","volume":"56","author":"MH Barnett","year":"2004","unstructured":"Barnett MH, Prineas JW (2004) Pathological heterogeneity in multiple sclerosis: a reflection of lesion stage? Ann Neurol 56:309","journal-title":"Ann Neurol"},{"key":"178_CR16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.21524","volume":"65","author":"MH Barnett","year":"2009","unstructured":"Barnett MH, Parratt JD, Cho ES, Prineas JW (2009) Immunoglobulins and complement in postmortem multiple sclerosis tissue. Ann Neurol 65:32\u201346","journal-title":"Ann Neurol"},{"key":"178_CR17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/ana.21311","volume":"63","author":"EC Breij","year":"2008","unstructured":"Breij EC, Brink BP, Veerhuis R et al (2008) Homogeneity of active demyelinating lesions in established multiple sclerosis. Ann Neurol 63:16\u201325","journal-title":"Ann Neurol"},{"key":"178_CR18","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/jnen\/63.3.262","volume":"63","author":"DJ Mahad","year":"2004","unstructured":"Mahad DJ, Trebst C, Kivisakk P et al (2004) Expression of chemokine receptors CCR1 and CCR5 reflects differential activation of mononuclear phagocytes in pattern II and pattern III multiple sclerosis lesions. J Neuropathol Exp Neurol 63:262\u2013273","journal-title":"J Neuropathol Exp Neurol"},{"key":"178_CR19","doi-asserted-by":"crossref","first-page":"18889","DOI":"10.1073\/pnas.0806310105","volume":"105","author":"FJ Quintana","year":"2008","unstructured":"Quintana FJ, Farez MF, Viglietta V et al (2008) Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc Natl Acad Sci U S A 105:18889\u201318894","journal-title":"Proc Natl Acad Sci U S A"},{"key":"178_CR20","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/brain\/awn105","volume":"131","author":"D Mahad","year":"2008","unstructured":"Mahad D, Ziabreva I, Lassmann H, Turnbull D (2008) Mitochondrial defects in acute multiple sclerosis lesions. Brain 131:1722\u20131735","journal-title":"Brain"},{"key":"178_CR21","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1093\/brain\/awm236","volume":"130","author":"C Marik","year":"2007","unstructured":"Marik C, Felts PA, Bauer J, Lassmann H, Smith KJ (2007) Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? Brain 130:2800\u20132815","journal-title":"Brain"},{"key":"178_CR22","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)67102-4","volume":"366","author":"M Keegan","year":"2005","unstructured":"Keegan M, Konig F, McClelland R et al (2005) Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet 366:579\u2013582","journal-title":"Lancet"},{"key":"178_CR23","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1007\/s00415-008-0883-x","volume":"255","author":"MR Haupts","year":"2008","unstructured":"Haupts MR, Schimrigk SK, Brune N et al (2008) Fulminant tumefactive multiple sclerosis: therapeutic implications of histopathology. J Neurol 255:1272\u20131273","journal-title":"J Neurol"},{"key":"178_CR24","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/978-3-642-81553-9_53","volume":"VII","author":"IV Allen","year":"1981","unstructured":"Allen IV, Glover G, Anderson R (1981) Abnormalities in the macroscopically normal white matter in cases of mild or spinal multiple sclerosis. Acta Neuropathol Suppl (Berl) VII:176\u2013181","journal-title":"Acta Neuropathol Suppl (Berl)"},{"key":"178_CR25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s100720170012","volume":"22","author":"IV Allen","year":"2001","unstructured":"Allen IV, McQuaid S, Mirakhur M, Nevin G (2001) Pathological abnormalities in the normal-appearing white matter in multiple sclerosis. Neurol Sci 22:141\u2013144","journal-title":"Neurol Sci"},{"issue":"Pt 1","key":"178_CR26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/brain\/121.1.103","volume":"121","author":"L Fu","year":"1998","unstructured":"Fu L, Matthews PM, De Stefano N et al (1998) Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain 121(Pt 1):103\u2013113","journal-title":"Brain"},{"key":"178_CR27","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/brain\/awh641","volume":"128","author":"A Kutzelnigg","year":"2005","unstructured":"Kutzelnigg A, Lucchinetti C, Stadelmann C et al (2005) Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128:2705\u20132712","journal-title":"Brain"},{"key":"178_CR28","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1750-3639.2003.tb00485.x","volume":"13","author":"U Graumann","year":"2003","unstructured":"Graumann U, Reynolds R, Steck AJ, Schaeren-Wiemers N (2003) Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult. Brain Pathol 13:554\u2013573","journal-title":"Brain Pathol"},{"key":"178_CR29","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/brain\/awm291","volume":"131","author":"T Zeis","year":"2008","unstructured":"Zeis T, Graumann U, Reynolds R, Schaeren-Wiemers N (2008) Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection. Brain 131:288\u2013303","journal-title":"Brain"},{"key":"178_CR30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.clim.2008.08.030","volume":"130","author":"M Montes","year":"2009","unstructured":"Montes M, Zhang X, Berthelot L et al (2009) Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells. Clin Immunol 130:133\u2013144","journal-title":"Clin Immunol"},{"key":"178_CR31","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1093\/brain\/awn190","volume":"131","author":"D Wheeler","year":"2008","unstructured":"Wheeler D, Bandaru VV, Calabresi PA, Nath A, Haughey NJ (2008) A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis. Brain 131:3092\u20133102","journal-title":"Brain"},{"key":"178_CR32","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1212\/01.wnl.0000250267.85698.7a","volume":"68","author":"I Pirko","year":"2007","unstructured":"Pirko I, Lucchinetti CF, Sriram S, Bakshi R (2007) Gray matter involvement in multiple sclerosis. Neurology 68:634\u2013642","journal-title":"Neurology"},{"key":"178_CR33","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1212\/01.wnl.0000237551.26858.39","volume":"67","author":"C Wegner","year":"2006","unstructured":"Wegner C, Esiri MM, Chance SA, Palace J, Matthews PM (2006) Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology 67:960\u2013967","journal-title":"Neurology"},{"key":"178_CR34","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/01.jnen.0000190067.20935.42","volume":"64","author":"M Vercellino","year":"2005","unstructured":"Vercellino M, Plano F, Votta B et al (2005) Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol 64:1101\u20131107","journal-title":"J Neuropathol Exp Neurol"},{"key":"178_CR35","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ana.1123","volume":"50","author":"JW Peterson","year":"2001","unstructured":"Peterson JW, Bo L, Mork S, Chang A, Trapp BD (2001) Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 50:389\u2013400","journal-title":"Ann Neurol"},{"key":"178_CR36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/1352458508096686","volume":"15","author":"M Calabrese","year":"2009","unstructured":"Calabrese M, Filippi M, Rovaris M et al (2009) Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study. Mult Scler 15:36\u201341","journal-title":"Mult Scler"},{"key":"178_CR37","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00415-008-0752-7","volume":"255","author":"M Calabrese","year":"2008","unstructured":"Calabrese M, De Stefano N, Atzori M et al (2008) Extensive cortical inflammation is associated with epilepsy in multiple sclerosis. J Neurol 255:581\u2013586","journal-title":"J Neurol"},{"key":"178_CR38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/brain\/122.1.17","volume":"122","author":"D Kidd","year":"1999","unstructured":"Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T (1999) Cortical lesions in multiple sclerosis. Brain 122:17\u201326","journal-title":"Brain"},{"key":"178_CR39","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/jnen\/62.7.723","volume":"62","author":"L Bo","year":"2003","unstructured":"Bo L, Vedeler C, Nyland H, Trapp B, Mork S (2003) Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 62:723\u2013732","journal-title":"J Neuropathol Exp Neurol"},{"key":"178_CR40","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1191\/1352458503ms917oa","volume":"9","author":"L Bo","year":"2003","unstructured":"Bo L, Vedeler C, Nyland H, Trapp B, Mork S (2003) Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler 9:323\u2013331","journal-title":"Mult Scler"},{"key":"178_CR41","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1750-3639.2006.00041.x","volume":"17","author":"A Kutzelnigg","year":"2007","unstructured":"Kutzelnigg A, Faber-Rod J, Bauer J, Lucchinetti CF et al (2007) Windespread demyelination in the cerebellar cortex in multiple sclerosis. Brain Pathol 17:38\u201344","journal-title":"Brain Pathol"},{"key":"178_CR42","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1212\/01.wnl.0000284601.54436.e4","volume":"70","author":"NM Moll","year":"2008","unstructured":"Moll NM, Rietsch AM, Ransohoff AJ et al (2008) Cortical demyelination in PML and MS: Similarities and differences. Neurology 70:336\u2013343","journal-title":"Neurology"},{"key":"178_CR43","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1750-3639.2004.tb00049.x","volume":"14","author":"B Serafini","year":"2004","unstructured":"Serafini B et al (2004) Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol 14:164\u2013174","journal-title":"Brain Pathol"},{"key":"178_CR44","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/brain\/awm038","volume":"130","author":"R Magliozzi","year":"2007","unstructured":"Magliozzi R, Howell O, Vora A, Serafini B et al (2007) Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 130:1089\u20131104","journal-title":"Brain"},{"issue":"12","key":"178_CR45","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1084\/jem.20071030","volume":"204","author":"B Serafini","year":"2007","unstructured":"Serafini B, Rosicarelli B, Franciotta D et al (2007) Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 204(12):2899\u20132912","journal-title":"J Exp Med"},{"key":"178_CR46","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/nen.0b013e318040b2de","volume":"66","author":"J Horssen van","year":"2007","unstructured":"van Horssen J, Brink BP, de Vries HE, van der Valk P, Bo L (2007) The blood-brain barrier in cortical multiple sclerosis lesions. J Neuropathol Exp Neurol 66:321\u2013328","journal-title":"J Neuropathol Exp Neurol"},{"key":"178_CR47","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1750-3639.2006.00043.x","volume":"17","author":"M Albert","year":"2007","unstructured":"Albert M, ANtel J, Bruck W, Stadelmann C (2007) Extensive cortical remeylination in patients with chronic multiple sclerosis. Brain Pathol 17:129\u2013138","journal-title":"Brain Pathol"},{"key":"178_CR48","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/nen.0b013e31812571b0","volume":"66","author":"M Vercellino","year":"2007","unstructured":"Vercellino M, Merola A, Piacentino C et al (2007) Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage. J Neuropathol Exp Neurol 66:732\u2013739","journal-title":"J Neuropathol Exp Neurol"},{"key":"178_CR49","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ana.21240","volume":"63","author":"A Dal Bianco","year":"2008","unstructured":"Dal Bianco A, Bradl M, Frischer J et al (2008) Multiple sclerosis and Alzheimer\u2019s disease. Ann Neurol 63:174\u2013183","journal-title":"Ann Neurol"},{"key":"178_CR50","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1474-4422(08)70191-1","volume":"7","author":"JJ Geurts","year":"2008","unstructured":"Geurts JJ, Barkhof F (2008) Grey matter pathology in multiple sclerosis. Lancet Neurol 7:841\u2013851","journal-title":"Lancet Neurol"},{"key":"178_CR51","first-page":"470","volume-title":"Greenfield\u2019s neuropathology","author":"DR Oppenheimer","year":"1976","unstructured":"Oppenheimer DR (1976) Demyelinating diseases. In: Blackwood W, Corsellis JAN (eds) Greenfield\u2019s neuropathology. Edward Arnold Ltd, London, pp 470\u2013499"},{"key":"178_CR52","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/jnnp.2008.148767","volume":"80","author":"CP Gilmore","year":"2009","unstructured":"Gilmore CP, Donaldson I, Bo L et al (2009) Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord. J Neurol Neurosurg Psychiatry 80:182\u2013187","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"178_CR53","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1750-3639.2008.00228.x","volume":"19","author":"CP Gilmore","year":"2008","unstructured":"Gilmore CP, Deluca GC, Bo L et al (2008) Spinal cord neuronal pathology in multiple sclerosis. Brain Pathol 19(4):642\u2013649","journal-title":"Brain Pathol"},{"key":"178_CR54","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/brain\/awp106","volume":"132","author":"EC Tallantyre","year":"2009","unstructured":"Tallantyre EC, Bo L, Al-Rawashdeh O et al (2009) Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease. Brain 132:1190\u20131199","journal-title":"Brain"},{"key":"178_CR55","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/brain\/awp070","volume":"132","author":"JM Frischer","year":"2009","unstructured":"Frischer JM, Bramow S, Dal-Bianco A et al (2009) The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 132:1175\u20131189","journal-title":"Brain"},{"key":"178_CR56","first-page":"211","volume":"27","author":"O Marburg","year":"1906","unstructured":"Marburg O (1906) Die sogenannte \u201cakute multiple sklerose\u201d. J Psychiatr Neurol 27:211\u2013312","journal-title":"J Psychiatr Neurol"},{"key":"178_CR57","first-page":"S113","volume":"22","author":"E Capello","year":"2001","unstructured":"Capello E, Roccataglioata L, Pagano F, Mancardi G (2001) Tumor-like multiple sclerosis (MS) lesions: neuropathological clues. J Neurosci 22:S113\u2013S116","journal-title":"J Neurosci"},{"key":"178_CR58","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1001\/archneurpsyc.1928.02210080044002","volume":"19","author":"J Balo","year":"1928","unstructured":"Balo J (1928) Encephalitis periaxalis concentrica. Arch Neurol 19:242\u2013263","journal-title":"Arch Neurol"},{"key":"178_CR59","volume-title":"Handbood of clinical neurology","author":"C Courville","year":"1970","unstructured":"Courville C (1970) Concentric sclerosis. In: Bruyn PVaG (ed) Handbood of clinical neurology. Elsevier, Amsterdam"},{"issue":"Pt 7","key":"178_CR60","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awn098","volume":"131","author":"CF Lucchinetti","year":"2008","unstructured":"Lucchinetti CF, Gavrilova RH, Metz I et al (2008) Clinical and radiographic spectrum of pathologically-confirmed tumefactive multiple sclerosis. Brain 131(Pt 7):1759\u20131775","journal-title":"Brain"},{"key":"178_CR61","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ana.410350105","volume":"35","author":"DL Yao","year":"1994","unstructured":"Yao DL, Webster H, Hudson LD et al (1994) Concentric sclerosis (Balo): morphometric and in situ hybridization study of lesions in six patients. Ann Neurol 35:18\u201330","journal-title":"Ann Neurol"},{"key":"178_CR62","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/brain\/awh457","volume":"128","author":"C Stadelmann","year":"2005","unstructured":"Stadelmann C, Ludwin SK, Tabira T et al (2005) Hypoxic preconditioning explains concentric lesions in Balo\u2019s type of multiple sclerosis. Brain 128:979\u2013987","journal-title":"Brain"},{"key":"178_CR63","first-page":"18","volume":"35","author":"C Devic","year":"1894","unstructured":"Devic C (1894) Myelite subaigue compliquee de nevrite optique. Bull Med 35:18\u201330","journal-title":"Bull Med"},{"key":"178_CR64","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","volume":"6","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk DM, Lennon V, Lucchinetti CF, Pittock SJ, Weinshenker BG (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6:805\u2013815","journal-title":"Lancet Neurol"},{"key":"178_CR65","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","volume":"125","author":"CF Lucchinetti","year":"2002","unstructured":"Lucchinetti CF, Mandler RN, McGavern D et al (2002) A role for humoral mechanisms in the pathogenesis of Devic\u2019s neuromyelitis optica. Brain 125:1450\u20131461","journal-title":"Brain"},{"key":"178_CR66","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ana.410340211","volume":"34","author":"RN Mandler","year":"1993","unstructured":"Mandler RN, Davis LE, Jeffery DR, Kornfeld M (1993) Devic\u2019s neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol 34:162\u2013168","journal-title":"Ann Neurol"},{"key":"178_CR67","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ et al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106\u20132112","journal-title":"Lancet"},{"key":"178_CR68","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"VA Lennon","year":"2005","unstructured":"Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR (2005) IgG marker of optic-spinal MS binds to the aquaporin-4 water channel. J Exp Med 202:473\u2013477","journal-title":"J Exp Med"},{"key":"178_CR69","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1073\/pnas.0437946100","volume":"100","author":"M Amiry-Moghaddam","year":"2003","unstructured":"Amiry-Moghaddam M, Otsuka T, Hurn PD et al (2003) An alpha-syntrophin-dependent pool of AQP4 in astroglial end-feet confers bidirectional water flow between blood and brain. Proc Natl Acad Sci U S A 100:2106\u20132111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"178_CR70","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.neuroscience.2004.07.055","volume":"129","author":"GP Nicchia","year":"2004","unstructured":"Nicchia GP, Nico B, Camassa LMA et al (2004) The role of aquaporin-4 in blood-brain barrier development and integrity: studies in animal and cell culture models. Neuroscience 129:935\u2013945","journal-title":"Neuroscience"},{"key":"178_CR71","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/brain\/awl371","volume":"130","author":"SF Roemer","year":"2007","unstructured":"Roemer SF, Parisi JE, Lennon VA et al (2007) Pattern specific loss of aquaporin 4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 130:1194\u20131205","journal-title":"Brain"},{"issue":"2","key":"178_CR72","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00401-006-0169-2","volume":"113","author":"C Sinclair","year":"2007","unstructured":"Sinclair C, Kirk J, Herron B, Fitzgerald U, McQuaid S (2007) Absence of aquaporin-4 expression in lesions of neuromyelitis optica but increased expression in multiple sclerosis lesions and normal-appearing white matter. Acta Neuropathol (Berl) 113(2):187\u2013194","journal-title":"Acta Neuropathol (Berl)"},{"key":"178_CR73","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1620\/tjem.209.269","volume":"209","author":"T Misu","year":"2006","unstructured":"Misu T, Fujihara K, Nakamura M et al (2006) Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report. Tohoku J Exp Med 209:269\u2013275","journal-title":"Tohoku J Exp Med"},{"key":"178_CR74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/01.WNL.0000289761.64862.ce","volume":"69","author":"SR Hinson","year":"2007","unstructured":"Hinson SR, Pittock SJ, Lucchinetti CF et al (2007) Pathologic potential of IgG binding to water channel exrtacellular domain in neuromyelitis optica. Neurology 69:1\u201311","journal-title":"Neurology"},{"issue":"11","key":"178_CR75","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1084\/jem.20081241","volume":"205","author":"SR Hinson","year":"2008","unstructured":"Hinson SR, Roemer SF, Lucchinetti CF et al (2008) Aquaporin-4 binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. J Exp Med 205(11):2473\u20132481","journal-title":"J Exp Med"},{"key":"178_CR76","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1179\/016164106X98251","volume":"28","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk DM (2006) The clinical course of acute disseminated encephalomyelitis. Neurol Res 28:341\u2013347","journal-title":"Neurol Res"},{"key":"178_CR77","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/jnnp.38.6.585","volume":"38","author":"M Hart","year":"1975","unstructured":"Hart M, Earle K (1975) Haemorrhagic and perivenous encephalitis: a clinical-pathological review of 38 cases. J Neurol Neurosurg Psychiatry 38:585\u2013591","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"178_CR78","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00005072-195007000-00001","volume":"9","author":"L Bogaert Van","year":"1950","unstructured":"Van Bogaert L (1950) Post-infectious encephalomyelitis and multiple sclerosis; the significance of perivenous encephalomyelitis. J Neuropathol Exp Neurol 9:219\u2013249","journal-title":"J Neuropathol Exp Neurol"},{"key":"178_CR79","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/1352458508097922","volume":"15","author":"HS Malhotra","year":"2009","unstructured":"Malhotra HS, Jain KK, Agarwal A et al (2009) Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy. Mult Scler 15:193\u2013203","journal-title":"Mult Scler"},{"key":"178_CR80","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1212\/WNL.54.7.1427","volume":"54","author":"JC Masdeu","year":"2000","unstructured":"Masdeu JC, Quinto C, Olivera C et al (2000) Open-ring imaging sign: highly specific for atypical brain demyelination. Neurology 54:1427\u20131433","journal-title":"Neurology"},{"key":"178_CR81","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/jon199662104","volume":"6","author":"JC Masdeu","year":"1996","unstructured":"Masdeu JC, Moreira J, Trasi S et al (1996) The open ring. A new imaging sign in demyelinating disease. J Neuroimaging 6:104\u2013107","journal-title":"J Neuroimaging"},{"key":"178_CR82","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ana.410330105","volume":"33","author":"J Kepes","year":"1993","unstructured":"Kepes J (1993) Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis: a study of 31 patients. Ann Neurol 33:18\u201327","journal-title":"Ann Neurol"},{"key":"178_CR83","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.clineuro.2004.02.016","volume":"106","author":"VV Brinar","year":"2004","unstructured":"Brinar VV (2004) Non-MS recurrent demyelinating diseases. Clin Neurol Neurosurg 106:197\u2013210","journal-title":"Clin Neurol Neurosurg"},{"key":"178_CR84","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1600-0404.1992.tb05490.x","volume":"86","author":"S Poser","year":"1992","unstructured":"Poser S, Luer W, Bruhn H et al (1992) Acute demyelinating disease. Classification and non-invasive diagnosis. Acta Neurol Scand 86:579\u2013585","journal-title":"Acta Neurol Scand"},{"key":"178_CR85","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/BF00596578","volume":"38","author":"C Chen","year":"1996","unstructured":"Chen C, Ro L, Wang L, Wong Y (1996) Balo\u2019s concentric sclerosis: MRI. Neuroradiology 38:322\u2013324","journal-title":"Neuroradiology"},{"key":"178_CR86","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/archneur.63.7.964","volume":"63","author":"SJ Pittock","year":"2006","unstructured":"Pittock SJ, Weinshenker BG, Lucchinetti CF et al (2006) Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 63:964\u2013968","journal-title":"Arch Neurol"},{"key":"178_CR87","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/01.wnl.0000343001.36493.ae","volume":"72","author":"SM Magana","year":"2009","unstructured":"Magana SM, Matiello M, Pittock SJ et al (2009) Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology 72:712\u2013717","journal-title":"Neurology"},{"key":"178_CR88","first-page":"27","volume":"98","author":"Y Morales","year":"2004","unstructured":"Morales Y, Parisi J, Lucchinetti CF (2006) The pathology of multiple sclerosis: evidence for heterogeneity. Adv Neurol 98:27\u201345","journal-title":"Adv Neurol"},{"key":"178_CR89","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0733-8619(18)30064-1","volume":"13","author":"BG Weinshenker","year":"1995","unstructured":"Weinshenker BG (1995) The natural history of multiple sclerosis. Neurol Clin 13:119\u2013146","journal-title":"Neurol Clin"},{"key":"178_CR90","volume-title":"Pathology and pathogenesis of multiple sclerosis","author":"CF Lucchinetti","year":"2003","unstructured":"Lucchinetti CF, Br\u00fcck W, Lassmann H (2003) Pathology and pathogenesis of multiple sclerosis, 2nd edn. Elsevier Science, USA","edition":"2"},{"key":"178_CR91","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00019052-200106000-00002","volume":"14","author":"CF Lucchinetti","year":"2001","unstructured":"Lucchinetti CF, Br\u00fcck W, Noseworthy J (2001) Multiple sclerosis: recent developments in neuropathology, pathogenesis, magnetic resonance imaging studies and treatment. Curr Opin Neurol 14:259\u2013269","journal-title":"Curr Opin Neurol"},{"key":"178_CR92","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/ana.410430409","volume":"43","author":"MK Storch","year":"1998","unstructured":"Storch MK, Piddlesden S, Haltia M et al (1998) Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination. Ann Neurol 43:465\u2013471","journal-title":"Ann Neurol"},{"key":"178_CR93","first-page":"1362","volume":"22","author":"E Karaarslan","year":"2001","unstructured":"Karaarslan E, Altintas A, Senol U et al (2001) Balo\u2019s concentric sclerosis: clinical and radiologic features of five cases. Am J Neuroradiol 22:1362\u20131367","journal-title":"Am J Neuroradiol"},{"key":"178_CR94","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s003810000331","volume":"17","author":"M Gallucci","year":"2001","unstructured":"Gallucci M, Caulo M, Cerone G, Masciocchi C (2001) Acquired inflammatory white matter disease. Childs Nerv Syst 17:202\u2013210","journal-title":"Childs Nerv Syst"},{"key":"178_CR95","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s11910-003-0086-x","volume":"3","author":"DM Wingerchuk","year":"2003","unstructured":"Wingerchuk DM (2003) Postinfectious encephalomyelitis. Curr Neurol Neurosci Rep 3:256\u2013264","journal-title":"Curr Neurol Neurosci Rep"},{"key":"178_CR96","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0022-510X(02)00043-6","volume":"197","author":"J Seze de","year":"2002","unstructured":"de Seze J, Stojkovic T, Ferriby D et al (2002) Devic\u2019s neuromyelitis optica: clinical, laboratory, MRI and outcome profile. J Neurol Sci 197:57\u201361","journal-title":"J Neurol Sci"},{"key":"178_CR97","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1034\/j.1600-0404.2003.02178.x","volume":"108","author":"L Fardet","year":"2003","unstructured":"Fardet L, Genereau T, Mikaeloff Y et al (2003) Devic\u2019s neuromyelitis optica: study of nine cases. Acta Neurol Scand 108:193\u2013200","journal-title":"Acta Neurol Scand"},{"key":"178_CR98","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","volume":"125","author":"CF Lucchinetti","year":"2002","unstructured":"Lucchinetti CF, Mandler R, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H (2002) A role for humoral mechanisms in the pathogenesis of Devic\u2019s neuromyelitis optica. Brain 125:1450\u20131461","journal-title":"Brain"},{"key":"178_CR99","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","volume":"53","author":"DM Wingerchuk","year":"1999","unstructured":"Wingerchuk DM, Hogancamp WF, O\u2019Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic\u2019s syndrome). Neurology 53:1107\u20131114","journal-title":"Neurology"},{"key":"178_CR100","volume-title":"Handbook of multiple sclerosis","author":"C Lucchinetti","year":"2006","unstructured":"Lucchinetti C (2006) The pathology of multiple sclerosis. What may it tell us? In: Cook SD (ed) Handbook of multiple sclerosis. Taylor and Francis, New York"},{"key":"178_CR101","volume-title":"Advances in multiple sclerosis","author":"C Lucchinetti","year":"2008","unstructured":"Lucchinetti C (2008) Pathological heterogeneity of idiopathic central nervous system. In: Rodriguez M (ed) Advances in multiple sclerosis. Springer-Verlag, Heidelberg"}],"container-title":["Seminars in Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-009-0178-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00281-009-0178-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-009-0178-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T10:11:58Z","timestamp":1559038318000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00281-009-0178-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,25]]},"references-count":101,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["178"],"URL":"https:\/\/doi.org\/10.1007\/s00281-009-0178-z","relation":{},"ISSN":["1863-2297","1863-2300"],"issn-type":[{"value":"1863-2297","type":"print"},{"value":"1863-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,25]]}}}